| Subject: | FDA Releases New Information about Ralstonia spp. associated with Vapotherm Respiratory Gas Administration Device |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 2 Nov 2005 - 11:43 am |
| Audience: Neonatologists, Pediatricians, Respiratory healthcare professionals and hospital clinical managers
The FDA has issued a Preliminary Public Health Notification on 10-27-05 to inform healthcare professionals of new information about a possible association between the Vapotherm 2000i Respiratory Gas Administration device, used to add moisture and warm breathing gases through a nasal cannula in patients receiving supplemental oxygen, and the occurrence of positive Ralstonia spp.... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCE:
Policies / Forms / Additional Resources:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. Other vendors have components of legislated requirements available online or on CD-ROM. However there is no other product that marries regulatory agency mandates with implementation tools, making the latest compliance information immediately available online. No other product provides an interpretative analysis, followed by a practical application tool, therefore providing users with an immediate solution to compliance problems. StayAlert! includes operational components for healthcare organizations, allowing complete facility compliance with mandated requirements, online. |
|
